These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 39096196)

  • 1. State inequities: Gaps in planned treatment for criminal legal referrals with opioid use disorder across two decades of US treatment admissions.
    Bormann NL; Weber AN; Oesterle TS; Miskle B; Lynch AC; Arndt S
    Am J Addict; 2024 Aug; ():. PubMed ID: 39096196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Black clients in expansion states who used opioids were more likely to access medication for opioid use disorder after ACA implementation.
    Johnson NL; Choi S; Herrera CN
    J Subst Abuse Treat; 2022 Feb; 133():108533. PubMed ID: 34218991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State level variation in substance use treatment admissions among criminal legal-referred individuals.
    Shearer RD; Winkelman TNA; Khatri UG
    Drug Alcohol Depend; 2022 Nov; 240():109651. PubMed ID: 36228467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with receipt of medication for opioid use disorder among pregnant individuals entering treatment programs in the U.S.
    Curran L; Manuel J
    Int J Drug Policy; 2024 Apr; 126():104342. PubMed ID: 38479161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019.
    Mauro PM; Gutkind S; Annunziato EM; Samples H
    JAMA Netw Open; 2022 Mar; 5(3):e223821. PubMed ID: 35319762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers and facilitators to the use of medication for opioid use disorder within the criminal justice system: Perspectives from clinicians.
    Booty MD; Harp K; Batty E; Knudsen HK; Staton M; Oser CB
    J Subst Use Addict Treat; 2023 Jun; 149():209051. PubMed ID: 37084815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends and age-related disparities in opioid use disorder treatment admissions for adolescents and young adults.
    Welsh JW; Dennis ML; Funk R; Mataczynski MJ; Godley MD
    J Subst Abuse Treat; 2022 Jan; 132():108584. PubMed ID: 34391589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medications for opioid use disorder among American Indians and Alaska natives: Availability and use across a national sample.
    Krawczyk N; Garrett B; Ahmad NJ; Patel E; Solomon K; Stuart EA; Saloner B
    Drug Alcohol Depend; 2021 Mar; 220():108512. PubMed ID: 33508692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States.
    Huhn AS; Hobelmann JG; Strickland JC; Oyler GA; Bergeria CL; Umbricht A; Dunn KE
    JAMA Netw Open; 2020 Feb; 3(2):e1920843. PubMed ID: 32031650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug court utilization of medications for opioid use disorder in high opioid mortality communities.
    Marlowe DB; Theiss DS; Ostlie EM; Carnevale J
    J Subst Abuse Treat; 2022 Oct; 141():108850. PubMed ID: 35931014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: A qualitative study.
    Morse E; Binswanger IA; Taylor E; Gray C; Stimmel M; Timko C; Harris AHS; Smelson D; Finlay AK
    J Subst Abuse Treat; 2021 Oct; 129():108353. PubMed ID: 34080564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs.
    Krawczyk N; Allen ST; Schneider KE; Solomon K; Shah H; Morris M; Harris SJ; Sherman SG; Saloner B
    Harm Reduct J; 2022 Aug; 19(1):95. PubMed ID: 36002850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laws for expanding access to medications for opioid use disorder: a legal analysis of 16 states & Washington D.C.
    Andraka-Christou B; Saloner B; Gordon AJ; Totaram R; Randall-Kosich O; Golan M; Stein BD
    Am J Drug Alcohol Abuse; 2022 Jul; 48(4):492-503. PubMed ID: 35772010
    [No Abstract]   [Full Text] [Related]  

  • 14. Association between availability of medications for opioid use disorder in specialty treatment and use of medications among patients: A state-level trends analysis.
    Solomon KT; Bandara S; Reynolds IS; Krawczyk N; Saloner B; Stuart E; Connolly E
    J Subst Abuse Treat; 2022 Jan; 132():108424. PubMed ID: 34144299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobile addiction treatment and harm reduction services as tools to address health inequities: a community case study of the Brockton Neighborhood Health Center mobile unit.
    Pinkhover A; Celata K; Baker T; Chatterjee A; Lunze K
    Front Public Health; 2024; 12():1407522. PubMed ID: 38957203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Availability of Medications for Opioid Use Disorder in Community Mental Health Facilities.
    Cantor J; Griffin BA; Levitan B; Mendon-Plasek SJ; Stein BD; Hunter SB; Ober AJ
    JAMA Netw Open; 2024 Jun; 7(6):e2417545. PubMed ID: 38888921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the impact on initiating medications for opioid use disorder of state policies expanding Medicaid and prohibiting substance use during pregnancy.
    Choi S; Stein MD; Raifman J; Rosenbloom D; Clark JA
    Drug Alcohol Depend; 2021 Dec; 229(Pt A):109162. PubMed ID: 34768053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Medicaid expansion on inclusion of medications for opioid use disorder in homeless adults' treatment plans.
    Swartz N; Odayappan S; Chatterjee A; Cutler D
    J Subst Use Addict Treat; 2023 Sep; 152():209059. PubMed ID: 37207834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcomes associated with medications for opioid use disorder (MOUD) among criminal justice-referred admissions to residential treatment in the U.S., 2015-2018.
    Stahler GJ; Mennis J; Stein LAR; Belenko S; Rohsenow DJ; Grunwald HE; Brinkley-Rubinstein L; Martin RA
    Drug Alcohol Depend; 2022 Jul; 236():109498. PubMed ID: 35605535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National trends in substance use treatment admissions for opioid use disorder among adults experiencing homelessness.
    Han BH; Doran KM; Krawczyk N
    J Subst Abuse Treat; 2022 Jan; 132():108504. PubMed ID: 34102461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.